Rofo 2003; 175(8): 1032-1041
DOI: 10.1055/s-2003-40909
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Embolisation bei symptomatischen Uterus-Myomen (UAE): Technik, Indikationsstellung und Ergebnisse

Embolization of Symptomatic Myomas (UAE): Technique, Indication and ResultsT.  J.  Vogl1 , V.  Jacobi1 , R.  Gätje2 , E.  Siebzehnrübl2 , S.  Zangos1
  • 1Institut für Diagnostische und Interventionelle Radiologie J.-W.-Goethe-Universität Frankfurt
  • 2Klinik für Gynäkologie und Geburtshilfe J.-W.-Goethe-Universität Frankfurt
Further Information

Publication History

Publication Date:
29 July 2003 (online)

Zusammenfassung:

Vorstellung der Indikationsstellung, der Technik und der Ergebnisse der Uterusarterienembolisation (UAE) bei symptomatischen Myomen. Interventionstechnische Voraussetzungen werden dargestellt, wie der Einsatz der DSA, der superselektiven Katheterisierung und der unterschiedlichen Embolisationsmaterialien wie Polyvinylalkohol (PVA) oder Microsphären, sowie Nachkontrollen nach UAE. Die technischen Erfolgsraten der UAE betragen zwischen 98 - 100 %. Die Ansprechraten liegen zwischen 85 - 94 % mit einem deutlichen oder kompletten Verlust der durch die Myome verursachten Symptomatik. Es wird eine Größenreduktion nach UAE von 48 bis zu 70 % der größten Myome erzielt. Bei Symptomen aufgrund der Größe der Myome erreicht man eine Besserung bei 85-96 %. Frauen die aufgrund von Menorrhagien mit der UAE behandelt werden, zeigen ein Ansprechen von 80 - 96 %. Die bisherigen Daten zur UAE belegen eine hohe Effektivität bei einer minimalen Komplikationsrate. Weitere Studien sind ausgerichtet auf die Langzeitergebnisse, den Einfluss auf die Fertilität und mögliche Spätkomplikationen.

Abstract

Presentation of indication, technique and results of transarterial uterine artery embolization (UAE) for the treatment of symptomatic myomas. Technical requirements are presented like DSA, catheters, superselective catheterisation and the different embolization materials as polyvinylalcohol (PVA) or microspheres, as well as the follow-up after UAE. The technical success rate of UAE is documented to range between 98 to 100 % and myomatous symptomatology disappears in 85 to 94 % of the cases. A reduction in the size of the myomata after UAE is observed between 48 to 70 %. A resolution of the hemorrhage disappears in 80 to 96 % of the cases immediately. Particulate embolization of the uterine artery is a new minimally invasive therapy in the management of symptomatic leiomyomas with a high efficiency and low rate of major complications. Further studies may prove the longterm results after UAE, the influence on fertility and possible late complications.

Literatur

  • 1 Buttram V C, Reiter R C. Uterine leiomyomata: etiology, symptomatology, and management.  Fertil Steril. 1981;  36 433-445
  • 2 Stewart E A. Uterine fibroids.  Lancet. 2001;  357 293-298
  • 3 Hausegger K A, Schreyer H, Bodhal H. Beckenarterienembolisation bei gynäkologischen Blutungen.  Fortschr Röntgenstr. 2002;  174 809-818
  • 4 Ravina J H, Herbreteau D, Ciraru-Vigneron N, Bouret J M, Houdart E, Aymard A, Merland J J. Arterial embolisation to treat uterine myomata.  Lancet. 1995;  346 671-672
  • 5 Günther R W, Siggelkow W, Vorwerk D, Neulen J, Rath W. Behandlung von Uterusmyomen durch perkutane Transkatherterembolisation.  Dtsch Arztebl. 2002;  99 1828-1835
  • 6 Watson G M, Walker W J. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women’s views of the success of the treatment.  Bjog. 2002;  109 129-135
  • 7 Spies J B, Roth A R, Jha R C, Gomez-Jorge J, Levy E B, Chang T C, Ascher S A. Leiomyomata treated with uterine artery embolization: factors associated with successful symptom and imaging outcome.  Radiology. 2002;  222 45-52
  • 8 Siskin G P, Tublin M E, Stainken B F, Dowling K, Dolen E G. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging.  AJR Am J Roentgenol. 2001;  177 297-302
  • 9 Hamm B. Stellenwert der MRT in der Diagnostik benigner und maligner Tumoren des Uterus.  Fortschr Röntgenstr. 1999;  170 327-337
  • 10 Nikolic B, Spies J B, Lundsten M J, Abbara S. Patient radiation dose associated with uterine artery embolization.  Radiology. 2000;  214 121-125
  • 11 Pelage J P, Soyer P, Le D ref, Dahan H, Coumbaras J, Kardache M, Rymer R. Uterine arteries: bilateral catheterization with a single femoral approach and a single 5-F catheter - technical note.  Radiology. 1999;  210 573-575
  • 12 Goodwin S C, McLucas B, Lee M, Chen G, Perrella R, Vedantham S, Muir S, Lai A, Sayre J W, DeLeon M. Uterine artery embolization for the treatment of uterine leiomyomata midterm results.  J Vasc Interv Radiol. 1999;  10 1159-1165
  • 13 Spies J B, Scialli A R, Jha R C, Imaoka I, Ascher S M, Fraga V M, Barth K H. Initial results from uterine fibroid embolization for symptomatic leiomyomata.  J Vasc Interv Radiol. 1999;  10 1149-1157
  • 14 Nikolic B, Spies J B, Campbell L, Walsh S M, Abbara S, Lundsten M J. Uterine artery embolization: reduced radiation with refined technique.  J Vasc Interv Radiol. 2001;  12 39-44
  • 15 Kröncke T J, Gauruder-Burmester A, Hamm B. Transarterielle Embolisation von Uterusmyomen - Eine neue Therapieoption bei symptomatischem Uterus myomatosus.  Fortschr Röntgenstr. 2002;  174 1227-1235
  • 16 Pelage J P, Le Dref O, Soyer P, Jacob D, Kardache M, Dahan H, Lassau J P, Rymer R. Arterial anatomy of the female genital tract: variations and relevance to transcatheter embolization of the uterus.  AJR Am J Roentgenol. 1999;  172 989-994
  • 17 Shlansky-Goldberg R, Cope C. A new twist on the Waltman loop for uterine fibroid embolization.  J Vasc Interv Radiol. 2001;  12 997-1000
  • 18 Pelage J P, Le Dref O, Soyer P, Kardache M, Dahan H, Abitbol M, Merland J J, Ravina J H, Rymer R. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up.  Radiology. 2000;  215 428-431
  • 19 Bradley E A, Reidy J F, Forman R G, Jarosz J, Braude P R. Transcatheter uterine artery embolisation to treat large uterine fibroids.  Br J Obstet Gynaecol. 1998;  105 235-240
  • 20 Klein A, Schwartz M L. Uterine artery embolization for the treatment of uterine fibroids: an outpatient procedure.  Am J Obstet Gynecol. 2001;  184 1556-1560 , discussion 1560 - 1553
  • 21 Siskin G P, Stainken B F, Dowling K, Meo P, Ahn J, Dolen E G. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients.  J Vasc Interv Radiol. 2000;  11 305-311
  • 22 Hutchins F L, Worthington-Kirsch R, Berkowitz R P. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri.  J Am Assoc Gynecol Laparosc. 1999;  6 279-284
  • 23 Worthington-Kirsch R, Fueredi G, Goodwin S, Machan L, Niedzwiecki G, Reidy J, Spies J, Walker W. Polyvinyl alcohol particle size for uterine artery embolization.  Radiology. 2001;  218 605-606
  • 24 Reidy J F, Bradley E A. Uterine artery embolization for fibroid disease.  Cardiovasc Intervent Radiol. 1998;  21 357-360
  • 25 Katsumori T, Nakajima K, Mihara T, Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: midterm results.  AJR Am J Roentgenol. 2002;  178 135-139
  • 26 Vashisht A, Studd J, Carey A, Burn P. Fatal septicaemia after fibroid embolisation.  Lancet. 1999;  354 307-308
  • 27 Spies J B, Benenati J F, Worthington-Kirsch R L, Pelage J P. Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata.  J Vasc Interv Radiol. 2001;  12 1059-1063
  • 28 Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas.  AJNR Am J Neuroradiol. 2000;  21 255-261
  • 29 Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin Y P, Aymard A, Rufenacht D, Merland J J. Trisacryl gelatin microspheres for therapeutic embolization, II: preliminary clinical evaluation in tumors and arteriovenous malformations.  AJNR Am J Neuroradiol. 1996;  17 541-548
  • 30 Laurent A, Beaujeux R, Wassef M, Rufenacht D, Boschetti E, Merland J J. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation.  AJNR Am J Neuroradiol. 1996;  17 533-540
  • 31 Nicholson T A, Pelage J P, Ettles D F. Fibroid calcification after uterine artery embolization: ultrasonographic appearance and pathology.  J Vasc Interv Radiol. 2001;  12 443-446
  • 32 McLucas B, Perrella R, Goodwin S, Adler L, Dalrymple J. Role of uterine artery Doppler flow in fibroid embolization.  J Ultrasound Med. 2002;  21 113-120 ,  quiz 122 - 113
  • 33 Muniz C J, Fleischer A C, Donnelly E F, Mazer M J. Three-dimensional color Doppler sonography and uterine artery arteriography of fibroids: assessment of changes in vascularity before and after embolization.  J Ultrasound Med. 2002;  21 129-133
  • 34 Burn P R, McCall J M, Chinn R J, Vashisht A, Smith J R, Healy J C. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries.  Radiology. 2000;  214 729-734
  • 35 Li W, Brophy D P, Chen Q, Edelman R R, Prasad P V. Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization.  J Magn Reson Imaging. 2000;  12 1004-1008
  • 36 Hagspiel K D, Matsumoto A H, Berr S S. Uterine fibroid embolization: assessment of treatment response using perfusion-weighted extraslice spin tagging (EST) magnetic resonance imaging.  J Magn Reson Imaging. 2001;  13 982-986
  • 37 Murase E, Siegelman E S, Outwater E K, Perez-Jaffe L A, Tureck R W. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment.  Radiographics. 1999;  19 1179-1197
  • 38 deSouza N M, Williams A D. Uterine arterial embolization for leiomyomas: perfusion and volume changes at MR imaging and relation to clinical outcome.  Radiology. 2002;  222 367-374
  • 39 Tranquart F, Brunereau L, Cottier J P, Marret H, Gallas S, Lebrun J L, Body G, Herbreteau D, Pourcelot L. Prospective sonographic assessment of uterine artery embolization for the treatment of fibroids.  Ultrasound Obstet Gynecol. 2002;  19 81-87
  • 40 Joyce A, Hessami S, Heller D. Leiomyosarcoma after uterine artery embolization. A case report.  J Reprod Med. 2001;  46 278-280
  • 41 Worthington-Kirsch R L, Popky G L, Hutchins F L. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response.  Radiology. 1998;  208 625-629
  • 42 Goodwin S C, Walker W J. Uterine artery embolization for the treatment of uterine fibroids.  Curr Opin Obstet Gynecol. 1998;  10 315-320
  • 43 Brunereau L, Herbreteau D, Gallas S, Cottier J P, Lebrun J L, Tranquart F, Fauchier F, Body G, Rouleau P. Uterine artery embolization in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients.  AJR Am J Roentgenol. 2000;  175 1267-1272
  • 44 Machan L, Goodwin S, Worthingthon-Kirsch R, Spies R. Fibroid embolization: Periprocedural care.  Seminars in Interventional Radiology. 2000;  17 247-254
  • 45 Vott S, Bonilla S M, Goodwin S C, Chen G, Wong G C, Lai A, Yegul T, DeLeon M. CT findings after uterine artery embolization.  J Comput Assist Tomogr. 2000;  24 846-848
  • 46 Abbara S, Spies J B, Scialli A R, Jha R C, Lage J M, Nikolic B. Transcervical expulsion of a fibroid as a result of uterine artery embolization for leiomyomata.  J Vasc Interv Radiol. 1999;  10 409-411
  • 47 Razavi M K, Wolanske K A, Hwang G L, Sze D Y, Kee S T, Dake M D. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization.  Radiology. 2002;  224 707-712
  • 48 Forsman L, Lundberg J, Scherten T. Conservative treatment of uterine arteriovenous fistula.  Acta Obstet Gynecol Scand. 1982;  61 85-87
  • 49 Stancato-Pasik A, Mitty H A, Richard H M, Eshkar N. Obstetric embolotherapy: effect on menses and pregnancy.  Radiology. 1997;  204 791-793
  • 50 Poppe W, van Assche F A, Wilms G, Favril A, Baert A. Pregnancy after transcatheter embolization of a uterine arteriovenous malformation.  Am J Obstet Gynecol. 1987;  156 1179-1180
  • 51 Vedantham S, Goodwin S C, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage.  Am J Obstet Gynecol. 1997;  176 938-948
  • 52 Ravina J H, Vigneron N C, Aymard A, Le D ref, Merland J J. Pregnancy after embolization of uterine myoma: report of 12 cases.  Fertil Steril. 2000;  73 1241-1243
  • 53 McLucas B, Goodwin S, Adler L, Rappaport A, Reed R, Perrella R. Pregnancy following uterine fibroid embolization.  Int J Gynaecol Obstet. 2001;  74 1-7
  • 54 Vashisht A, Smith J R, Thorpe-Beeston G, McCall J. Pregnancy subsequent to uterine artery embolization.  Fertil Steril. 2001;  75 1246-1248
  • 55 Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch R, Lipman J, Machan L, Sacks D, Sterling K, Lewis C. Training standards for physicians performing uterine artery embolization for leiomyomata: consensus statement developed by the Task Force on Uterine Artery Embolization and the standards division of the Society of Cardiovascular & Interventional Radiology - August 2000.  J Vasc Interv Radiol. 2001;  12 19-21
  • 56 Andersen P E, Lund N, Justesen P, Munk T, Elle B, Floridon C. Uterine artery embolization of symptomatic uterine fibroids. Initial success and short-term results.  Acta Radiol. 2001;  42 234-238
  • 57 McLucas B, Reed R A, Goodwin S, Rappaport A, Adler L, Perrella R, Dalrymple J. Outcomes following unilateral uterine artery embolisation.  Br J Radiol. 2002;  75 122-126
  • 58 Spies J B, Ascher S A, Roth A R, Kim J, Levy E B, Gomez-Jorge J. Uterine artery embolization for leiomyomata.  Obstet Gynecol. 2001;  98 29-34
  • 59 Ravina J H, Aymard A, Ciraru-Vigneron N, Ledreff O, Merland J J. [Arterial embolization of uterine myoma: results apropos of 286 cases].  J Gynecol Obstet Biol Reprod (Paris). 2000;  29 272-275
  • 60 LaMorte A I, Lalwani S, Diamond M P. Morbidity associated with abdominal myomectomy.  Obstet Gynecol. 1993;  82 897-900
  • 61 Iverson R E, Chelmow D, Strohbehn K, Waldman L, Evantash E G. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas.  Obstet Gynecol. 1996;  88 415-419
  • 62 Carlson K J, Miller B A, Fowler F J. The Maine Women’s Health Study: Outcomes of hysterectomy. Obstet Gynecol 1994 83: 556-565
  • 63 Lumsden M A. Embolization versus myomectomy versus hysterectomy: which is best, when?.  Hum Reprod. 2002;  17 253-259
  • 64 Graves E J. National hospital discharge survey. Vital Health Stat 13 1992: 1-62

Dr. med. Stephan Zangos

Institut für Diagnostische und Interventionelle Radiologie
J.-W.-Goethe-Universität Frankfurt

Theodor-Stern-Kai 7

60590 Frankfurt

Email: Zangos@em.uni-frankfurt.de